The partnership brings together Salipro’s tech for stabilising drug targets from Boehringer’s drug discovery programmes.

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

After adjustment for confounding variables, researchers found no increased suicide risk for GLP-1 receptor agonists versus DPP-4 inhibitors or SGLT-2 inhibitors.

A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide—also known as ...

Semaglutide may help reduce alcohol cravings and intake, according to a clinical trial. Participants receiving the drug drank ...

Protagonists and antagonists do not function without the other. For a narrative to progress, the protagonist must have a driving force, as well as obstacles in the way of achieving their goals.

Use of GLP-1 receptor agonists to treat type 2 diabetes is not associated with an increased risk of suicidality compared with ...

Garth Mullins and the B.C. Association for People on Opioid Maintenance, have filed the complaint on behalf of those “who paid out-of-pocket private clinic access fees” for opioid agonist ...

II or III of schedule 2 of the Misuse of Drugs Act 1971. Section 5A(1)(b) and (2) RTA 1988 provides for an offence of driving or being in charge of a motor vehicle with a proportion of a specified ...

Blockbuster drugs are medications that generate $1 billion+ in annual sales. Drug patents typically last 20 years, but market exclusivity is often shorter. Post-patent, revenue can drop by 80% as ...